Skip to main content

Table 3 Impact of baseline patient characteristics on potency rates two years post-SBRT

From: Potency preservation following stereotactic body radiation therapy for prostate cancer

Characteristics % Potent 2 years after SBRT p value
Age    
  ≤ 65 y/o pre-RT 66.7% 0.580
  >65 y/o pre-RT 47.4%  
Race    
  White 51.2% 0.574
  Non-white 57.4%  
Partner status    
  Partnered 54.3% 0.297
  Non-partnered 55.0%  
Charlson comorbidity index (CCI)   
  0 58.9% 0.007*
  ≥1 35.3%  
Body mass index (BMI)   
  < 30 60.9% 0.943
  ≥ 30 38.5%  
Risk group (D’ Amico’ s)   
  Low risk 54.8% 0.420
  Intermediate-High Risk 54.2%  
Work status   
  Working 54.7% 0.173
  Non-working 54.1%  
Pre- treatment SHIM   
  ≥ 22 40.91% 0.127
  < 22 67.39%  
Sexual aid    
  None 43.8% 0.010*#
  Yes 60.3%  
SBRT Dose    
  36.25 Gy 50.0% 0.933
  < 36.25 Gy 55.0%  
  1. *Significant in univariate analysis; # Significant multivariate analysis.